Human insulin delivery system is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting for human being.
This report contains market size and forecasts of Human Insulin Delivery System in global, including the following market information:
Global Human Insulin Delivery System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Insulin Delivery System Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Insulin Delivery System companies in 2021 (%)
The global Human Insulin Delivery System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Automatic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Insulin Delivery System include BD, Novo Nordisk, Medtronic, Sanofi, ELI Lilly and Company, Ypsomed Holding, Animas Corporation, Tandem Diabetes Care and Insulet Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Insulin Delivery System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Insulin Delivery System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Insulin Delivery System Market Segment Percentages, by Type, 2021 (%)
Automatic
Manual
Global Human Insulin Delivery System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Insulin Delivery System Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Homecare
Global Human Insulin Delivery System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Insulin Delivery System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Insulin Delivery System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Insulin Delivery System revenues share in global market, 2021 (%)
Key companies Human Insulin Delivery System sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Insulin Delivery System sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Roche
Johnson & Johnson
Microport